Delivery Order SPE2DB22D3301-SPE2DB24FX6XX
Award Date 12/12/23
Potential Completion Date 12/13/23
Potential Value $3.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,834.02 firm fixed-price delivery order contract is for the supply of DOXEPIN HCL 3 MG TABLET 30S, with a performance period through February 14, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,128.88 firm fixed price delivery order is for the supply of Doxepin HCL 3 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Doxepin HCL 3 mg tablets. The contract has a ceiling value of $2,467.05 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,196.53, is for the delivery of 4,564,460,309 units of doxepin hydrochloride 3 mg tablets. The contract has an ultimate completion date of May 2, 2024 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $1,700.37, is for the delivery of 4565947872 DOXEPIN HCL 3 MG TABLET 30S. It is a firm-fixed-price delivery order contract with a completion date of September 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,577.58 Firm Fixed Price Delivery Order is for the supply of Doxepin Hydrochloride 3 mg Tablets. The contract has an ultimate completion date of April 23, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,538.63 firm fixed price delivery order is for the supply of 4,563,216,285 units of Doxepin HCL 6 mg tablets in 30-count packages. No set-aside was used for this award, which is scheduled for completion by January 3, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,694.71 firm fixed-price delivery order is for the supply of 4,562,470,814 units of 3 mg Doxepin HCL tablets, to be completed by October 16, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract, valued at $6,241.45, is for the delivery of Doxepin HCL 3 mg tablets to support military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of 3mg doxepin hydrochloride tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,057.62 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...